301 related articles for article (PubMed ID: 16178890)
21. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
[TBL] [Abstract][Full Text] [Related]
22. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.
Kabashima A; Yao T; Maehara Y; Tsuneyoshi M
Gastric Cancer; 2005; 8(4):220-7. PubMed ID: 16328596
[TBL] [Abstract][Full Text] [Related]
23. Confocal endomicroscopy for phenotypic diagnosis of gastric cancer.
Banno K; Niwa Y; Miyahara R; Nakamura M; Nagaya T; Nagasaka T; Watanabe O; Ando T; Kawashima H; Ohmiya N; Itoh A; Hirooka Y; Goto H
J Gastroenterol Hepatol; 2010 Apr; 25(4):712-8. PubMed ID: 20492327
[TBL] [Abstract][Full Text] [Related]
24. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
25. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
[TBL] [Abstract][Full Text] [Related]
26. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
[TBL] [Abstract][Full Text] [Related]
27. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
28. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype.
Motoshita J; Nakayama H; Taniyama K; Matsusaki K; Yasui W
Pathol Int; 2006 Apr; 56(4):200-5. PubMed ID: 16634965
[TBL] [Abstract][Full Text] [Related]
29. Mucin and differentiation in Epstein-Barr virus-associated gastric carcinoma.
Nakamura Y; Yanai H; Kitou T; Matsubara Y; Hirano A; Okamoto T; Yoshida T; Okita K; Matsusaki K
Hepatogastroenterology; 2005; 52(64):1066-70. PubMed ID: 16001631
[TBL] [Abstract][Full Text] [Related]
30. [Mucin histochemical study of differentiated adenocarcinoma of stomach].
Egashira Y
Nihon Shokakibyo Gakkai Zasshi; 1994 Apr; 91(4):839-48. PubMed ID: 7513368
[TBL] [Abstract][Full Text] [Related]
31. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
32. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.
Ohmura K; Tamura G; Endoh Y; Sakata K; Takahashi T; Motoyama T
Hum Pathol; 2000 Sep; 31(9):1031-5. PubMed ID: 11014567
[TBL] [Abstract][Full Text] [Related]
33. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
Pan W; Ishii H; Ebihara Y; Gobe G
J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
[TBL] [Abstract][Full Text] [Related]
34. "Very well differentiated tubular adenocarcinoma" of the stomach: its endoscopic and histopathological characteristics.
Fujii T; Yoshida S; Abe K; Saito D; Yamaguchi H; Oguro Y; Maruyama K; Ochiai A; Hirota T
Jpn J Clin Oncol; 1994 Jun; 24(3):128-34. PubMed ID: 8007422
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical detection of gastric mucin in normal and disease states.
Taylor KL; Mall AS; Barnard RA; Ho SB; Cruse JP
Oncol Res; 1998; 10(9):465-73. PubMed ID: 10223622
[TBL] [Abstract][Full Text] [Related]
36. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of submucosal gastric carcinoma with lymph node metastatic disease.
Son HJ; Song SY; Kim S; Noh JH; Sohn TS; Kim DS; Rhee JC
Histopathology; 2005 Feb; 46(2):158-65. PubMed ID: 15693888
[TBL] [Abstract][Full Text] [Related]
38. Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Aihara R; Mochiki E; Kamiyama Y; Ohno T; Asao T; Kuwano H
J Surg Oncol; 2006 May; 93(6):491-7. PubMed ID: 16615152
[TBL] [Abstract][Full Text] [Related]
39. The clinical meaning of mucin phenotype and Epstein-Barr virus infection in gastric cancer.
Nakamura Y; Yanai H; Kitoh T; Matsubara Y; Hirano A; Okamoto T; Yoshida T; Nishikawa J; Okita K
Hepatogastroenterology; 2008; 55(81):41-5. PubMed ID: 18507075
[TBL] [Abstract][Full Text] [Related]
40. Dysplasia of nonmetaplastic gastric mucosa. A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma.
Ghandur-Mnaymneh L; Paz J; Roldan E; Cassady J
Am J Surg Pathol; 1988 Feb; 12(2):96-114. PubMed ID: 3341515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
